| Histidine metabolism |
1.83 |
3.34e-2 |
16/22 (72.73%) |
HNMT;MAOA;ALDH3A1;...
|
| Malaria |
-1.67 |
5.00e-2 |
44/50 (88%) |
IL1B;THBS2;TGFB1;...
|
| Vibrio cholerae infection |
-1.68 |
4.88e-2 |
44/50 (88%) |
ATP6V1D;KCNQ1;TCIRG1;...
|
| ECM-receptor interaction |
-1.70 |
4.17e-2 |
80/88 (90.91%) |
THBS1;TNN;VWF;...
|
| Gastric acid secretion |
-1.72 |
3.34e-2 |
63/76 (82.89%) |
ATP1B4;ATP1A1;ADCY1;...
|
| Insulin signaling pathway |
-1.76 |
2.03e-2 |
121/137 (88.32%) |
FLOT1;ACACA;SREBF1;...
|
| Adipocytokine signaling pathway |
-1.77 |
1.97e-2 |
64/69 (92.75%) |
STK11;TNFRSF1A;ACSL3;...
|
| Citrate cycle (TCA cycle) |
-1.78 |
2.03e-2 |
30/30 (100%) |
SUCLA2;IDH3B;DLST;...
|
| Melanoma |
-1.79 |
1.96e-2 |
68/72 (94.44%) |
FGF5;FGF4;PIK3R1;...
|
| Insulin resistance |
-1.80 |
2.20e-2 |
96/108 (88.89%) |
PRKAB2;SOCS3;PIK3R1;...
|
| Legionellosis |
-1.81 |
2.13e-2 |
51/57 (89.47%) |
RAB1A;ARF1;IL1B;...
|
| PPAR signaling pathway |
-1.85 |
1.58e-2 |
66/74 (89.19%) |
ACOX3;ANGPTL4;APOA1;...
|
| Cardiac muscle contraction |
-1.89 |
1.36e-2 |
64/87 (73.56%) |
ATP1B4;ATP1A1;ATP1A3;...
|
| Dilated cardiomyopathy |
-1.91 |
1.36e-2 |
86/96 (89.58%) |
CACNG1;CACNA1S;TGFB3;...
|
| Hypertrophic cardiomyopathy |
-1.92 |
1.81e-2 |
81/90 (90%) |
PRKAB2;CACNG1;CACNA1S;...
|
| Regulation of lipolysis in adipocytes |
-1.92 |
2.03e-2 |
52/55 (94.55%) |
NPR1;PLAAT3;PIK3R3;...
|
| AMPK signaling pathway |
-1.96 |
2.71e-2 |
106/120 (88.33%) |
PPP2R5A;PPP2CA;PPP2R5B;...
|
